AI-generated summary
The authors evaluated a picosecond 755-nm alexandrite laser with a diffractive lens array in 20 Asian women with melasma treated over three sessions. They report a significant reduction in mean MASI score from 9.0 to 6.5 and mostly mild, short-lived side effects. The study had no control group, so the authors' conclusion of effectiveness should be interpreted cautiously.
- Participants
- 20
- Who or what was studied
- Twenty Asian female patients with melasma and Fitzpatrick skin type IV, median age 45 years (range 27 to 55)
- Wavelengths
- 755 nm
- Limits stated in the abstract
- The abstract describes a small sample of 20 patients and does not mention a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 0.4 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.